CD274 and nonpapillary renal cell carcinoma: Recently, many studies (KEYNOTE 426 [4], Checkmate 214 [5] and JAVELIN RENAL 101 [49]) reported that PD-L1 expression was insufficient to predict which metastasis ccRCC patient could benefit from ICI therapy.